ID   AMPE_HUMAN              Reviewed;         957 AA.
AC   Q07075; Q504U2;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 203.
DE   RecName: Full=Glutamyl aminopeptidase;
DE            Short=EAP;
DE            EC=3.4.11.7 {ECO:0000269|PubMed:10692253, ECO:0000269|PubMed:23888046};
DE   AltName: Full=Aminopeptidase A;
DE            Short=AP-A;
DE   AltName: Full=Differentiation antigen gp160;
DE   AltName: CD_antigen=CD249;
GN   Name=ENPEP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 242-251; 300-316 AND
RP   369-377, AND VARIANTS ARG-213 AND ALA-218.
RC   TISSUE=Kidney cortex;
RX   PubMed=8346219; DOI=10.1073/pnas.90.15.7069;
RA   Nanus D.M., Engelstein D., Gastl G.A., Gluck L., Vidal M.J., Morrison M.,
RA   Finstad C.L., Bander N.H., Albino A.P.;
RT   "Molecular cloning of the human kidney differentiation antigen gp160: human
RT   aminopeptidase A.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:7069-7073(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-213.
RC   TISSUE=Kidney;
RX   PubMed=8244382; DOI=10.1006/geno.1993.1386;
RA   Li L., Wang J., Cooper M.D.;
RT   "cDNA cloning and expression of human glutamyl aminopeptidase
RT   (aminopeptidase A).";
RL   Genomics 17:657-664(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-213.
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-213.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10692253; DOI=10.1053/plac.1999.0456;
RA   Ino K., Nagasaka T., Okamoto T., Uehara C., Nakazato H., Nakashima N.,
RA   Mizutani S.;
RT   "Expression of aminopeptidase A in human gestational choriocarcinoma cell
RT   lines and tissues.";
RL   Placenta 21:63-72(2000).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-607.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-124; ASN-324; ASN-607; ASN-763
RP   AND ASN-773.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0007744|PDB:4KX7, ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB, ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD}
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 76-957 IN COMPLEX WITH SUBSTRATE;
RP   CALCIUM AND INHIBITORS, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   SUBUNIT, ACTIVE SITE, METAL-BINDING SITES, SUBSTRATE-BINDING, COFACTOR,
RP   SITE, MUTAGENESIS OF THR-356 AND ARG-887, AND GLYCOSYLATION AT ASN-98;
RP   ASN-197; ASN-324; ASN-340; ASN-554; ASN-597; ASN-678; ASN-763; ASN-801 AND
RP   ASN-828.
RX   PubMed=23888046; DOI=10.1074/jbc.m113.494955;
RA   Yang Y., Liu C., Lin Y.L., Li F.;
RT   "Structural insights into central hypertension regulation by human
RT   aminopeptidase A.";
RL   J. Biol. Chem. 288:25638-25645(2013).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-887.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Regulates central hypertension through its calcium-modulated
CC       preference to cleave N-terminal acidic residues from peptides such as
CC       angiotensin II. {ECO:0000305|PubMed:23888046}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Release of N-terminal glutamate (and to a lesser extent
CC         aspartate) from a peptide.; EC=3.4.11.7;
CC         Evidence={ECO:0000269|PubMed:10692253, ECO:0000269|PubMed:23888046};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:23888046};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:23888046};
CC   -!- ACTIVITY REGULATION: Substrate specificity is modulated by calcium
CC       which enhances the enzymatic activity for cleavage of acidic residues
CC       while reducing its activity with basic residues. Inhibited by
CC       aminopeptidase inhibitors amastatin and bestatin.
CC       {ECO:0000269|PubMed:10692253, ECO:0000269|PubMed:23888046}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000269|PubMed:23888046}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10692253};
CC       Single-pass type II membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in choriocarcinoma cancer cell lines (at
CC       protein level) (PubMed:10692253). Expressed by epithelial cells of the
CC       proximal tubule cells and the glomerulus of the nephron. Also found in
CC       a variety of other tissues. {ECO:0000269|PubMed:10692253}.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L14721; AAA35522.1; -; mRNA.
DR   EMBL; L12468; AAA16876.1; -; mRNA.
DR   EMBL; AC017068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC094770; AAH94770.1; -; mRNA.
DR   CCDS; CCDS3691.1; -.
DR   PIR; A47531; A47531.
DR   RefSeq; NP_001968.3; NM_001977.3.
DR   PDB; 4KX7; X-ray; 2.15 A; A=76-957.
DR   PDB; 4KX8; X-ray; 2.40 A; A=76-957.
DR   PDB; 4KX9; X-ray; 2.25 A; A=76-957.
DR   PDB; 4KXA; X-ray; 2.40 A; A=76-957.
DR   PDB; 4KXB; X-ray; 2.40 A; A=76-957.
DR   PDB; 4KXC; X-ray; 2.40 A; A=76-957.
DR   PDB; 4KXD; X-ray; 2.15 A; A=76-957.
DR   PDBsum; 4KX7; -.
DR   PDBsum; 4KX8; -.
DR   PDBsum; 4KX9; -.
DR   PDBsum; 4KXA; -.
DR   PDBsum; 4KXB; -.
DR   PDBsum; 4KXC; -.
DR   PDBsum; 4KXD; -.
DR   AlphaFoldDB; Q07075; -.
DR   SMR; Q07075; -.
DR   BioGRID; 108342; 6.
DR   IntAct; Q07075; 5.
DR   STRING; 9606.ENSP00000265162; -.
DR   BindingDB; Q07075; -.
DR   ChEMBL; CHEMBL3439; -.
DR   DrugBank; DB00142; Glutamic acid.
DR   MEROPS; M01.003; -.
DR   GlyConnect; 1940; 8 N-Linked glycans (6 sites).
DR   GlyCosmos; Q07075; 20 sites, 13 glycans.
DR   GlyGen; Q07075; 21 sites, 8 N-linked glycans (6 sites), 5 O-linked glycans (4 sites).
DR   iPTMnet; Q07075; -.
DR   PhosphoSitePlus; Q07075; -.
DR   SwissPalm; Q07075; -.
DR   BioMuta; ENPEP; -.
DR   DMDM; 296439445; -.
DR   EPD; Q07075; -.
DR   jPOST; Q07075; -.
DR   MassIVE; Q07075; -.
DR   MaxQB; Q07075; -.
DR   PaxDb; Q07075; -.
DR   PeptideAtlas; Q07075; -.
DR   ProteomicsDB; 58502; -.
DR   Antibodypedia; 979; 578 antibodies from 37 providers.
DR   DNASU; 2028; -.
DR   Ensembl; ENST00000265162.10; ENSP00000265162.5; ENSG00000138792.10.
DR   GeneID; 2028; -.
DR   KEGG; hsa:2028; -.
DR   MANE-Select; ENST00000265162.10; ENSP00000265162.5; NM_001977.4; NP_001968.3.
DR   UCSC; uc003iab.5; human.
DR   AGR; HGNC:3355; -.
DR   CTD; 2028; -.
DR   DisGeNET; 2028; -.
DR   GeneCards; ENPEP; -.
DR   HGNC; HGNC:3355; ENPEP.
DR   HPA; ENSG00000138792; Tissue enhanced (intestine, kidney).
DR   MIM; 138297; gene.
DR   neXtProt; NX_Q07075; -.
DR   OpenTargets; ENSG00000138792; -.
DR   PharmGKB; PA27790; -.
DR   VEuPathDB; HostDB:ENSG00000138792; -.
DR   eggNOG; KOG1046; Eukaryota.
DR   GeneTree; ENSGT00940000156946; -.
DR   HOGENOM; CLU_003705_0_1_1; -.
DR   InParanoid; Q07075; -.
DR   OMA; NVWSQFV; -.
DR   OrthoDB; 3085317at2759; -.
DR   PhylomeDB; Q07075; -.
DR   TreeFam; TF300395; -.
DR   BRENDA; 3.4.11.7; 2681.
DR   PathwayCommons; Q07075; -.
DR   Reactome; R-HSA-2022377; Metabolism of Angiotensinogen to Angiotensins.
DR   SignaLink; Q07075; -.
DR   BioGRID-ORCS; 2028; 11 hits in 1153 CRISPR screens.
DR   ChiTaRS; ENPEP; human.
DR   GenomeRNAi; 2028; -.
DR   Pharos; Q07075; Tchem.
DR   PRO; PR:Q07075; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q07075; protein.
DR   Bgee; ENSG00000138792; Expressed in jejunal mucosa and 141 other tissues.
DR   ExpressionAtlas; Q07075; baseline and differential.
DR   Genevisible; Q07075; HS.
DR   GO; GO:0045177; C:apical part of cell; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005903; C:brush border; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004177; F:aminopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0042277; F:peptide binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0002003; P:angiotensin maturation; NAS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IDA:MGI.
DR   GO; GO:0008283; P:cell population proliferation; IDA:MGI.
DR   GO; GO:0007267; P:cell-cell signaling; NAS:UniProtKB.
DR   GO; GO:0032835; P:glomerulus development; ISS:UniProtKB.
DR   GO; GO:0043171; P:peptide catabolic process; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; IBA:GO_Central.
DR   GO; GO:0008217; P:regulation of blood pressure; IBA:GO_Central.
DR   GO; GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; IDA:UniProtKB.
DR   CDD; cd09601; M1_APN-Q_like; 1.
DR   Gene3D; 1.25.50.20; -; 1.
DR   Gene3D; 2.60.40.1910; -; 1.
DR   Gene3D; 1.10.390.10; Neutral Protease Domain 2; 1.
DR   Gene3D; 2.60.40.1730; tricorn interacting facor f3 domain; 1.
DR   InterPro; IPR045357; Aminopeptidase_N-like_N.
DR   InterPro; IPR042097; Aminopeptidase_N-like_N_sf.
DR   InterPro; IPR024571; ERAP1-like_C_dom.
DR   InterPro; IPR034016; M1_APN-typ.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR014782; Peptidase_M1_dom.
DR   InterPro; IPR027268; Peptidase_M4/M1_CTD_sf.
DR   PANTHER; PTHR11533:SF242; GLUTAMYL AMINOPEPTIDASE; 1.
DR   PANTHER; PTHR11533; PROTEASE M1 ZINC METALLOPROTEASE; 1.
DR   Pfam; PF11838; ERAP1_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   Pfam; PF17900; Peptidase_M1_N; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   SUPFAM; SSF63737; Leukotriene A4 hydrolase N-terminal domain; 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminopeptidase; Calcium; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Membrane; Metal-binding; Metalloprotease; Protease; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN           1..957
FT                   /note="Glutamyl aminopeptidase"
FT                   /id="PRO_0000095095"
FT   TOPO_DOM        1..18
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        19..39
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        40..957
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          44..83
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        57..71
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        394
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:23888046, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXD"
FT   BINDING         223
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXB"
FT   BINDING         357..361
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   BINDING         393
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:23888046, ECO:0007744|PDB:4KX7,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   BINDING         397
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:23888046, ECO:0007744|PDB:4KX7,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   BINDING         416
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095,
FT                   ECO:0000269|PubMed:23888046, ECO:0007744|PDB:4KX7,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   BINDING         887
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXC,
FT                   ECO:0007744|PDB:4KXD"
FT   SITE            221
FT                   /note="Binds calcium which modulates its enzyme activity"
FT                   /evidence="ECO:0000269|PubMed:23888046"
FT   SITE            479
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXB, ECO:0007744|PDB:4KXC,
FT                   ECO:0007744|PDB:4KXD"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine; atypical"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX7"
FT   CARBOHYD        124
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        197
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX7, ECO:0007744|PDB:4KX8,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXB, ECO:0007744|PDB:4KXC,
FT                   ECO:0007744|PDB:4KXD"
FT   CARBOHYD        324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:23888046, ECO:0007744|PDB:4KX7,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   CARBOHYD        340
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC"
FT   CARBOHYD        554
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX7, ECO:0007744|PDB:4KX8,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   CARBOHYD        589
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        597
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KXD"
FT   CARBOHYD        607
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        678
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX7, ECO:0007744|PDB:4KX8,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXB, ECO:0007744|PDB:4KXC,
FT                   ECO:0007744|PDB:4KXD"
FT   CARBOHYD        763
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:23888046, ECO:0007744|PDB:4KX7,
FT                   ECO:0007744|PDB:4KX8, ECO:0007744|PDB:4KX9,
FT                   ECO:0007744|PDB:4KXA, ECO:0007744|PDB:4KXB,
FT                   ECO:0007744|PDB:4KXC, ECO:0007744|PDB:4KXD"
FT   CARBOHYD        773
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        801
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX7, ECO:0007744|PDB:4KX8,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXB, ECO:0007744|PDB:4KXC,
FT                   ECO:0007744|PDB:4KXD"
FT   CARBOHYD        828
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:23888046,
FT                   ECO:0007744|PDB:4KX7, ECO:0007744|PDB:4KX8,
FT                   ECO:0007744|PDB:4KX9, ECO:0007744|PDB:4KXA,
FT                   ECO:0007744|PDB:4KXB, ECO:0007744|PDB:4KXC,
FT                   ECO:0007744|PDB:4KXD"
FT   VARIANT         213
FT                   /note="Q -> R (in dbSNP:rs10004516)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:15815621, ECO:0000269|PubMed:8244382,
FT                   ECO:0000269|PubMed:8346219"
FT                   /id="VAR_030359"
FT   VARIANT         218
FT                   /note="V -> A (in dbSNP:rs1126483)"
FT                   /evidence="ECO:0000269|PubMed:8346219"
FT                   /id="VAR_030360"
FT   VARIANT         437
FT                   /note="R -> H (in dbSNP:rs34949711)"
FT                   /id="VAR_057056"
FT   VARIANT         861
FT                   /note="S -> R (in dbSNP:rs35812243)"
FT                   /id="VAR_057057"
FT   VARIANT         887
FT                   /note="R -> T (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036047"
FT   MUTAGEN         356
FT                   /note="T->V: Reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:23888046"
FT   MUTAGEN         887
FT                   /note="R->A: Reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:23888046"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          97..109
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           110..112
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          114..125
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          129..135
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          138..148
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          157..163
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          168..177
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:4KXD"
FT   STRAND          186..195
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          200..210
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          213..221
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            223..226
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           227..230
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          241..250
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          253..259
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          261..276
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           284..286
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          289..292
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          295..300
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          306..311
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           313..319
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           320..336
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          342..344
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          346..353
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          355..359
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          364..368
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           369..371
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            376..378
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           381..397
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            401..403
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          404..408
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           409..412
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           413..430
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           432..434
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           436..443
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           445..451
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           467..472
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           476..493
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           495..508
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          512..514
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           516..527
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           531..535
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           536..538
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          545..550
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            551..553
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          554..559
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            574..577
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          581..587
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          590..596
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          618..620
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           621..623
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   STRAND          625..630
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           633..646
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           647..649
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           652..667
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           673..678
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            679..682
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           683..685
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           689..705
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            706..708
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           712..731
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           739..754
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           758..771
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            780..782
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           783..794
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           797..809
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           813..823
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           829..838
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   TURN            842..844
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           847..849
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           850..858
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           863..873
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           875..882
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           887..891
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           892..896
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           902..914
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           919..921
FT                   /evidence="ECO:0007829|PDB:4KX7"
FT   HELIX           922..953
FT                   /evidence="ECO:0007829|PDB:4KX7"
SQ   SEQUENCE   957 AA;  109244 MW;  AB6407432A45A7C6 CRC64;
     MNFAEREGSK RYCIQTKHVA ILCAVVVGVG LIVGLAVGLT RSCDSSGDGG PGTAPAPSHL
     PSSTASPSGP PAQDQDICPA SEDESGQWKN FRLPDFVNPV HYDLHVKPLL EEDTYTGTVS
     ISINLSAPTR YLWLHLRETR ITRLPELKRP SGDQVQVRRC FEYKKQEYVV VEAEEELTPS
     SGDGLYLLTM EFAGWLNGSL VGFYRTTYTE NGQVKSIVAT DHEPTDARKS FPCFDEPNKK
     ATYTISITHP KEYGALSNMP VAKEESVDDK WTRTTFEKSV PMSTYLVCFA VHQFDSVKRI
     SNSGKPLTIY VQPEQKHTAE YAANITKSVF DYFEEYFAMN YSLPKLDKIA IPDFGTGAME
     NWGLITYRET NLLYDPKESA SSNQQRVATV VAHELVHQWF GNIVTMDWWE DLWLNEGFAS
     FFEFLGVNHA ETDWQMRDQM LLEDVLPVQE DDSLMSSHPI IVTVTTPDEI TSVFDGISYS
     KGSSILRMLE DWIKPENFQK GCQMYLEKYQ FKNAKTSDFW AALEEASRLP VKEVMDTWTR
     QMGYPVLNVN GVKNITQKRF LLDPRANPSQ PPSDLGYTWN IPVKWTEDNI TSSVLFNRSE
     KEGITLNSSN PSGNAFLKIN PDHIGFYRVN YEVATWDSIA TALSLNHKTF SSADRASLID
     DAFALARAQL LDYKVALNLT KYLKREENFL PWQRVISAVT YIISMFEDDK ELYPMIEEYF
     QGQVKPIADS LGWNDAGDHV TKLLRSSVLG FACKMGDREA LNNASSLFEQ WLNGTVSLPV
     NLRLLVYRYG MQNSGNEISW NYTLEQYQKT SLAQEKEKLL YGLASVKNVT LLSRYLDLLK
     DTNLIKTQDV FTVIRYISYN SYGKNMAWNW IQLNWDYLVN RYTLNNRNLG RIVTIAEPFN
     TELQLWQMES FFAKYPQAGA GEKPREQVLE TVKNNIEWLK QHRNTIREWF FNLLESG
//
